Difference between revisions of "Quell relief"
(→Public Policy: update) |
(→Public Policy: update) |
||
Line 101: | Line 101: | ||
== Public Policy == | == Public Policy == | ||
<!-- Information related to any regulations (law, patents, ISOs, government recommendations and so on.) --> | <!-- Information related to any regulations (law, patents, ISOs, government recommendations and so on.) --> | ||
− | Food and Drug Administration contains | + | Food and Drug Administration contains database consisting of three chapters (I. Food and Drug Administration, Department of Healt and Human Services; II. Drug Enforcement Administration, Department of Justice; III. Office of National Drug Control Policyy), where each device is sorted and classified according to specific properties. This Database is actually part of the main one called [http://www.ecfr.gov/cgi-bin/text-idx?SID=3ee286332416f26a91d9e6d786a604ab&mc=true&tpl=/ecfrbrowse/Title21/21tab_02.tpl Electronic Code of Federal Regulations (eCFR)]. It this database, Quell comes under the chapter I. Under classification name are mentioned categories stimulator, nerve, transcutaneous, over-the-counter. |
== Related Technologies, Project or Scientific Research == | == Related Technologies, Project or Scientific Research == |
Revision as of 02:02, 10 November 2015
QUELL RELIEF | |
---|---|
Category | Therapeutic wearables |
Developer | NeuroMetrix |
Announced | Oct 2015 |
Released | Consumers: 2015 |
Price | 249 USD |
Weight | 62 g |
Dimensions | 98 x 74 x 11 mm |
Controls | smartphone |
Standalone[1] | |
https://www.quellrelief.com/product |
Contents
Main characteristics
Purpose
Quell wearable is device designated for treatment of chronic pain. It works on principle of transcutaneous electrical nerve stimulation, which causes release of endogenous opiates affecting pain relief.
Company & People
Important Dates
1965 - Melzack and Wall proposed first conceptual model for mechanism which could lead to pain relief
1970s - Developement of TENS (Transcutaneous electrical nerve stimulation)
Ethical Issues
Health Risks
Official statement about side effects is that there are none[1]. Usage is 100% drug free, with clearance by FDA (Food and Drug Administration)
Enhancement/Therapy/Treatment
Quell wearable device has primarily therapeutical function. It was developed on purpose to palliate chronical pain which basically has origin in these four diseases:
Public & Media Impact and Presentation
Public Policy
Food and Drug Administration contains database consisting of three chapters (I. Food and Drug Administration, Department of Healt and Human Services; II. Drug Enforcement Administration, Department of Justice; III. Office of National Drug Control Policyy), where each device is sorted and classified according to specific properties. This Database is actually part of the main one called Electronic Code of Federal Regulations (eCFR). It this database, Quell comes under the chapter I. Under classification name are mentioned categories stimulator, nerve, transcutaneous, over-the-counter.
Related Technologies, Project or Scientific Research
References
- ↑ Shows if the device is a standalone wearable computer or if it needs to be connected to a processing unit to function.